UNIT vs VRTX · P/E 2.7, rev $722.6M vs P/E 30, rev $12.00B
Uniti Group Inc (UNIT) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Uniti Group Inc (UNIT) is a reit - specialty company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported UNIT revenue for 2025-09-30 was $722.6M. Net income was $1.61B. Revenue was up 147.3% from 2024-09-30 to 2025-09-30. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
UNIT currently screens at market cap $2.96B and trailing P/E 2.7. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the UNIT and VRTX stock pages for the full models.
Not investment advice.